Skip to main content

Advertisement

Log in

Case Report: Successful Treatment of Relapsing Polychondritis and Crohn’s Disease with Tocilizumab

  • Case Report
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Relapsing polychondritis is a rare autoimmune inflammatory syndrome with no established treatment guidelines or placebo-controlled clinical trials. Most treatment plans are based on anecdotal case reports. We present a case of refractory relapsing polychondritis in a patient with Crohn’s disease. She has responded well and has achieved clinical remission on treatment with interleukin-6 receptor inhibitor tocilizumab.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data Availability

All authors had access to the data and materials.

Code Availability

Not applicable.

References

  1. Haslag-Minoff J, Regunath H. Relapsing polychondritis. N Engl J Med. 2018;378:1715.

    Article  Google Scholar 

  2. Mathian A, Miyara M, Cohen-Aubart F, et al. Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol. 2016;30:316–33.

    Article  Google Scholar 

  3. Chopra R, Chaudhary N, Kay J. Relapsing Polychondritis. Rheum Dis Clin N Am. 2013;39:263–76.

    Article  Google Scholar 

  4. Puechal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Relapsing polychondritis. Joint Bone Spine. 2014;81:118–24.

    Article  CAS  Google Scholar 

  5. Sharma A, Gnanapandithan K, Sharma K, Sharma S. Relapsing polychondritis: a review. Clin Rheumatol. 2013;32:1575–83.

    Article  Google Scholar 

  6. Trentham DE, Le CH. Relapsing Polychondritis. Ann Intern Med. 1998;129:114–22.

    Article  CAS  Google Scholar 

  7. McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55(3):193–215.

    Article  CAS  Google Scholar 

  8. Kemta Lekpa F, Kraus VB, Chevalier X. Biologics in relapsing polychondritis: a literature review. Semin Arthritis Rheum. 2012;41:712–9.

    Article  Google Scholar 

  9. Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P. Biologics in relapsing polychondritis: a case series. Clin Exp Rheumatol. 2013;31:937–9.

    Google Scholar 

  10. Stael R, Smith V, Wittoek R, Creytens D, Mielants H. Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review. Clin Rheumatol. 2015;34:189–93.

    Article  Google Scholar 

  11. Vitale A, Sota J, Rigante D, et al. Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives. Curr Rheumatol Rep. 2016;18:3.

    Article  Google Scholar 

  12. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8(Suppl 2):S3. https://doi.org/10.1186/ar1917.

    Article  CAS  Google Scholar 

  13. Thorne IC, Jawad ASM, Sutcliffe N. Refractory relapsing polychondritis, responsive to IL-6 blockade. Grand Rounds. 2015;15:1–3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors had a role in the creation of this manuscript. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Lindsay N. Moy.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

The patient featured in this case report has given written consent for the case to be published.

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moy, L.N., Brandwein, S.R. Case Report: Successful Treatment of Relapsing Polychondritis and Crohn’s Disease with Tocilizumab. SN Compr. Clin. Med. 4, 226 (2022). https://doi.org/10.1007/s42399-022-01310-1

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s42399-022-01310-1

Keywords

Navigation